Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer-Reference-Cited by-同舟云学术

Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer

Published:1989-10 Issue:3 Volume:13 Page:243-250
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Burford-Mason Aileen,Gyte Gillian M. L.,Watkins Sylvia M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02106574.pdf

Reference16 articles.

1. Burnet FM: Immunological surveillance in neoplasia. Transplant Rev 7: 3–25, 1971

2. Braun DP, Harris JE: Relationship of leucocyte numbers, immunoregulatory cell function and phytohaemagglutinin responsiveness in cancer patients. JNCI 67: 809–814, 1981

3. Watkins SM: Cancer prognosis predicted by preoperative lymphocyte responsivenessin vitro. Br J Surg 63: 433–434, 1976

4. Park SK, Brody JL, Wallace HA, Blakemore WS: Immunosuppressive effect of surgery. Lancet 1: 53–55, 1971

5. Gyte GML, Watkins SM: Lymphocyte transformation in cancer patients: variation in results according to technique. J Clin Pathol 31: 125–128, 1978

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant breast cancer vaccine improves disease specific survival of breast cancer patients with depressed lymphocyte immunity;Surgical Oncology;2013-09

2. Heightened Risk of Breast Cancer Following Pregnancy: Could Lasting Systemic Immune Alterations Contribute?: Figure 1.;Cancer Epidemiology Biomarkers & Prevention;2007-06

3. What's in a Name? Neuroimmunomodulation or Psychoneuroimmunology?;Annals of the New York Academy of Sciences;2006-01-25

4. Immune dysfunction and micrometastases in women with breast cancer;Breast Cancer Research and Treatment;2005-05

5. Lymphocyte subsets and T h 1/T h 2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome;Cancer Immunology, Immunotherapy;2003-06-12